PPARG and fatty liver disease: atRA has also been reported to reduce hepatic lipid accumulation in liver steatosis model animals by repressing PPARγ and to induce lipolysis by a PPARβ/δ-mediated increase in the levels of HSL in adipocytes (28, 29).